Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Weekly Dose-Dense Paclitaxel in Extensive Stage SCLC
NCT00005646Phase 2Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Apr 2000
- Primary completion
- Jan 2004
- Modality
- Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in small cell lung cancer (SCLC), sponsored by Cancer and Leukemia Group B. Started Apr 2000; status: completed.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
small cell lung cancer (SCLC)
Beyond the preview
Go deeper on NCT00005646.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00005646.